<--- Back to Details
First PageDocument Content
Clinical medicine / Neurochemistry / Medicine / Sodium channel blockers / Alglucosidase alfa / Calcium channel blockers / Glycogen storage disease type II / Ketamine / Treprostinil / Eptifibatide
Date: 2010-05-26 09:39:24
Clinical medicine
Neurochemistry
Medicine
Sodium channel blockers
Alglucosidase alfa
Calcium channel blockers
Glycogen storage disease type II
Ketamine
Treprostinil
Eptifibatide

LUMIZYME (alglucosidase alfa) for Injection

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 245,04 KB

Share Document on Facebook

Similar Documents

CMTF005 - Food is Medicine - Checklist_Debranded

DocID: 1xVMk - View Document

Cardiac electrophysiology / Medical devices / Neuroprosthetics / Medicine / Technology / Computing / Cybernetics / Implantable cardioverter-defibrillator / International Statistical Classification of Diseases and Related Health Problems / Universal Software Radio Peripheral / Artificial cardiac pacemaker / Radio-frequency identification

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

DocID: 1xVge - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

DocID: 1xUza - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_edited

DocID: 1xTtU - View Document

PDF Document

DocID: 1xSqy - View Document